Form D · Pharmaceuticals
CannaPharmaRX, Inc.
Arvada, CO · CIK 0001608686
Offering snapshot reported Jun 18, 2014 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2014 | Initial | $500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-219456
Source: Form D, filed Jun 18, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Cohen | Director, Executive |
| Gerry Crocker | Director, Executive |
| Gary Herick | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7609 Ralston Road
Arvada, CO, 80002
Arvada, CO, 80002